
Kevin Madagan
Prescription Drug and Medical Device Promotion – New FDA Draft Guidance on Presenting Risk Information
Life Sciences Legal Update ·
Commentary: FDA’s New Good Reprint Practice Rule
Life Sciences Legal Update ·
Review Of Final FDA Guidance On Off-Label Use Publications
Life Sciences Legal Update ·
DDMAC’s Increased Scrutiny of Promotional Materials
Life Sciences Legal Update ·
Review of Proposed FDA Guidance on Off-Label Use Publications
Life Sciences Legal Update ·